A study was undertaken regarding the prevalence of bovine viral diarrhoea virus (BVDV) antibodies in bovine sera which tested negative for rinderpest and peste des petits ruminants virus antibodies. The samples were collected between January 1996 and December 1997. A total of 439 samples (327 cattle and 112 buffalo from 17 states of India) were tested using a commercial enzyme-linked immunosorbent assay (ELISA) kit. The mean prevalence of BVDV antibodies in cattle was 15.29% (50/327) in 16 states compared to 23.21% (26/112) in buffalo in 9 states, with an overall prevalence of 17.31% (76/439) in 17 states. The serological evidence that BVDV infection is widespread in India is of utmost practical importance because of the clinical resemblance to rinderpest. A differential diagnosis between these two diseases is critical in view of the declaration by India of provisional freedom from rinderpest disease; active sero-surveillance is to begin in 2000 to achieve certification of freedom from rinderpest infection by the Office International des Epizooties.
Introduction
Bovine viral diarrhoea (BVD) is caused by bovine viral diarrhoea virus (BVDV), a positive-sense, single-stranded, enveloped RNA virus of the genus Pestivirus and family Flaviviridae (12) . Cattle are the animals most commonly infected but the virus can also be found in sheep, goats and wild ruminants, which may serve as reservoirs. Non-cytopathogenic (non-cp) and cytopathogenic (cp) biotypes of the virus exist (11) and persistent infection with non-cp biotype is mainly responsible for the maintenance and transmission of the virus in nature. Calves which become pre-natally infected with non-cp BVDV develop a persistent infection for life and become major reservoirs of BVDV within the herd. When exposed to cp BVDV during the adult stage, these cattle may suffer from fatal mucosal disease (MD).
The disease has a world-wide distribution and the BVDV antibody prevalence ranges from 50% to 90% in cattle (4, 7) . Prevalences of 56% and 79.2% BVDV antibodies have been recorded, using an enzyme-linked immunosorbent assay (ELISA), in bovine sera from Brazil (3) and Zimbabwe (9), respectively. A very high herd prevalence of 95% was recorded in England and Wales, when the bulk tank milk samples from 1,070 dairy herds were tested using ELISA (10) . The economic losses associated with BVDV are due to abortion, still births, congenital abnormalities, increased neonatal mortality, prenatal and postnatal growth retardation and persistently infected calves.
Cattle infected with BVDV may develop multiple and diverse clinical manifestations. The wide spectrum of disease associated with BVDV infection includes sub-clinical infections, BVD, congenital deformities in calves and acute and chronic MD. The majority of infections (70%-90%) in susceptible cattle are sub-clinical with the development of neutralising antibodies (1) . However, infection with BVD is acute in seronegative, immunocompetent cattle. Clinical signs may include pyrexia, depression, inappetence, oculonasal discharge and occasionally oral lesions characterised by erosions or shallow ulcerations and foul smelling watery diarrhoea; high morbidity is experienced but mortality is low. The virus causes immunosuppression in the host and may potentiate or enhance the pathogenicity of co-infecting micro-organisms (e.g. infectious bovine rhinotracheitis, parainfluenza type-3, corona and rotaviruses, and Pasteurella and Salmonella spp.).
In contrast, the clinical manifestation of cp BVDV in persistently infected animals is MD, a highly fatal disease with low morbidity and high mortality. The incidence of clinical MD in a herd is expected to be less than 5% in animals of up to 2 years of age, however, in occasional epidemics, 25% or more may develop the disease (2) . The acute form of MD is characterised by pyrexia, depression, necrotic erosions on lips, buccal mucosa and gums, mucopurulent nasal discharge, profuse watery diarrhoea, lacrimation, corneal oedema and lameness. Dehydration and death generally occur 5 to 7 days after the onset of clinical signs. Chronic MD is characterised by inappetence, weight loss, progressive emaciation, continued or intermittent diarrhoea, nasal and persistent ocular discharge and chronic erosive lesions involving the skin, which may fail to heal.
In India, the presence of BVDV neutralising antibodies in 43.56% (44/101) of bovine sera was first reported in 1989 in the State of Gujarat. Buffalo showed 65.96% (31/47) prevalence, compared to 40.63% (13/32) in cattle, while 22 sera from apparently healthy in-contact cattle were seronegative (8) . Apart from this study, the current status of the infection in India has not been investigated.
Materials and methods
Bovine sera (439) from 327 cattle and 112 buffalo, from 17 states of India, which had been confirmed negative for rinderpest and peste des petits ruminants (PPR) virus antibodies by competitive ELISA, were selected randomly from the national serum bank facility of the Project on Animal Disease Monitoring and Surveillance (ADMAS). The clinical history of these animals was not known.
A commercial ELISA kit was used to test for BVDV antibodies. The principle of the ELISA technique in a typical positive reaction is that the specific binding of BVDV antibodies in the test sample to the BVDV antigen makes the latter unavailable for binding to the precoated capturing monoclonal antibody (mAb) as well as to the peroxidase-conjugated detecting mAb. In contrast, the absence of specific BVDV antibodies in the test sample ensures the availability of the virus antigen for binding to the precoated and peroxidase conjugated mAbs, resulting in a negative reaction with colour development.
In brief, the ELISA protocol included incubation of undiluted test sera together with BVDV antigen in a capturing mAb coated microtitre ELISA plate, at room temperature, for 1 h, on a rotary shaker. The plates were washed 6 times with washing buffer and then incubated with peroxidase conjugated detecting mAb for 1 h, at room temperature. After washing the plates, the chromogen (tetra methyl benzidine)/ substrate solution was added. Finally, the enzyme reaction was stopped after 15 min and the plates were read at 450 nm. Appropriate positive and negative controls provided by the manufacturer were included in every test run. Serum samples showing percentage inhibition (PI) equal to or greater than 50% were considered positive for BVDV antibody and those with a PI less than 50%, as negative.
Results
The commercial ELISA kit for BVDV antibodies was user-friendly and the results were reproducible. Detection of antibodies to BVDV using commercial ELISA kits has been previously described by Graham et al. (5, 6) .
The mean prevalence of BVDV antibodies in cattle was 15.29% (50/327) in 16 states, with 23.21% (26/112) in buffalo in 9 states (Table I ). The overall prevalence was 17.31% (76/439) in 17 states. Antibodies for BVDV were not detected in the sera of either cattle or buffalo from the states of Jammu and Kashmir and Punjab, and were detected only in cattle sera from Assam, Madhya Pradesh, Manipur, Mizoram and Nagaland. This preliminary observation should be followed up by a further large-scale survey to establish whether BVD exists in these states.
Discussion
This limited study was undertaken to investigate the BVD situation in view of the ongoing rinderpest eradication campaign in India. A representative sample of rinderpest and PPR negative sera (439) was selected randomly to provide a wide geographic coverage over 17 states. The serological evidence indicates widespread BVD infection with the interesting characteristic of higher incidence in buffalo. Although BVD was recorded for the first time in India in 1989, in the state of Gujarat (8), BVD/MD has not been critically investigated as an important disease, perhaps due to clinical similarities with rinderpest. Some of the sporadic and isolated cases of rinderpest-like disease, especially in the more endemic southern states are very probably BVD/MD. The clinical forms of BVD/MD now assume greater importance as India provisionally declared freedom from rinderpest disease in mid-1995 and a national sero-surveillance campaign is to The results of this study cannot answer the question of how long BVD has existed in the indigenous cattle/buffalo population of India. The introduction of BVDV into the country through import of semen and persistently infected exotic cattle in the past few decades cannot be ruled out. Extensive and continuous use of BVDV contaminated semen, primary bovine cell culture vaccines and biological products, especially tissue culture rinderpest vaccine, may have aided the rapid spread of BVDV throughout the country.
The problem deserves immediate attention and field veterinarians need to be educated about the complexities of this disease. Adequate BVD diagnostic facilities are to be provided in all state level disease investigation laboratories in India.
Conclusions
The serological evidence of BVD infection in 15.29% of cattle and 23.21% of buffalo was recorded in 16 and 9 states of India respectively. Currently, this disease is of particular interest in terms of the differential diagnosis of BVD from rinderpest, as the country has been provisionally declared free from rinderpest disease. An epidemiological study is suggested to identify immunotolerant persistent infected animals, which are likely to develop MD; this could be undertaken using commercially available diagnostic kits. 
Resumen
Los autores describen un estudio para determinar la prevalencia de anticuerpos contra el virus de la diarrea viral bovina (VDVB) en sueros bovinos que no presentaban anticuerpos contra los virus de la peste bovina y de la peste de pequeños rumiantes. Para dicho estudio se reunieron muestras entre enero de 1996 y diciembre de 1997. Se analizó un total de 439 muestras (tomadas de 327 vacunos y 112 búfalos de 17 estados de la India), utilizando un kit comercial de ensayo inmunoenzimático (ELISA). La prevalencia media de anticuerpos contra el VDVB en el ganado vacuno resultó de un 15,29% (50/327) en 16 estados, y en los búfalos de un 23,21% (26/112) en 9 estados. La prevalencia total se cifraba en un 17,31% (76/439) para los 17 estados. La demostración serológica de que la infección por el VDVB está muy extendida en la India reviste gran importancia, dada la semejanza clínica que guarda esa enfermedad con la peste bovina. Para que la India pueda declararse provisionalmente libre de la peste bovina, es esencial un diagnóstico diferencial, capaz de discriminar entre ambas enfermedades. En 2000 empezarán a aplicarse medidas de serovigilancia activa, encaminadas a conseguir que la Oficina Internacional de Epizootias declare el país libre de infección de peste bovina.
